Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19
Clinical trial NCT05276375 · COMPLETED
Trial details
- NCT number
- NCT05276375
- Sponsor
- Dr. Frank Behrens
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2023-06-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.